Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
severe adverse events (SAE) occurs in the Phase I clinical trial using the drug BIA 10-2474 including one death
1-5(2)7-8-11(16)19-9(7)10-13(3)14(8
L002 was administered through IP injection at 500 µg/100 µl twice a week for 3 weeks in xenografts models
Smiles: CC(=O)NCCC1=CNC2C=C(O)C(=CC1=2)OC
The abl proto-oncogene is expressed in all cell types
Phosphoramide mustard (cyclohexanamine) Catalog No.:M24974-C severe adverse events (SAE) occursPhosphoramide mustard cyclohexanamine is a biologically active metabolite of Cyclophosphamide (HY 17420), with anticancer activitiy. Phosphoramide mustard cyclohexanamine induces DNA damage. Product information CAS Number: 1566 15 0 Molecular Weight: 320. 20 Formula: C10H24Cl2N3O2P Chemical Name: amino[bis(2 chloroethyl)amino]phosphinic acid; cyclohexanamine Smiles: NC1CCCCC1. NP(O)(=O)N(CCCl)CCCl InChiKey: BGTIPRUDEMNRIP UHFFFAOYSA N InChi: InChI=1S
US$ 55.30
US$ 69.30
US$ 76.30
US$ 69.30
US$ 36.40
US$ 48.30
US$ 69.30